80% of Tuberculosis Patients Don’t Have Persistent Cough
A study of more than 600,000 individuals shows that 4 in 5 with TB have no persistent cough, previously believed to be the most common symptom of the infectious disease.
A study of more than 600,000 individuals shows that 4 in 5 with TB have no persistent cough, previously believed to be the most common symptom of the infectious disease.
The machine learning technique can help detect whether antibiotic use is critical for patients with these infections.
Simple breathing exercises done twice daily while using a mobile phone app can help relieve the symptoms of long COVID.
Hospital systems across the country are reporting more and more cases of RSV, COVID-19 and influenza as the seasonal Tripledemic is surging.
Read MoreLong thought to only infect the respiratory tract, a new study has found that RSV can infect nerve cells, cause nerve damage, and enter the spinal cord, potentially granting access to the central nervous system.
Read MoreCanadians with noncommunicable diseases such as heart or chronic lung ailments were disproportionately impacted by the COVID-19 pandemic.
Read MoreAstraZeneca and Sanofi’s Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) in neonates and infants entering or during their first RSV season.
Read MoreChinese researchers examined the trends in hospital visits for acute and chronic respiratory diseases between 2018 and 2021 using the national health insurance data from Wuhan.
Read MoreCOVAX, an international initiative for equitable access to COVID-19 vaccines will end on December 31, after providing a total of 2 billion COVID vaccines to more than 90 countries.
Read MoreFungal pneumonia caused by Pneumocystis is difficult study, but scientists have developed a promising new model using precision-cut slices of lung tissue to allow lab cultures of the fungus.
Read MoreResearchers may have uncovered why people with hybrid immunity against COVID-19 are better able to resist reinfection than those with single immunity.
Read MoreLung airway cells of people with alcohol use disorder developed “enhanced inflammation” three days after being infected with SARS-CoV-2.
Read MoreA new study identifies alterations in the transcriptomic signatures in human olfactory mucosal cells of individuals with Alzheimer’s disease following SARS-CoV-2 infection, potentially contributing to exacerbated COVID-19 outcomes.
Read MoreA study shows not only that SARS-CoV-2 is found in the lungs of certain individuals for up to 18 months after infection but also that its persistence appears to be linked to a failure of innate immunity.
Read MoreBeing overweight can impair the body’s antibody response to SARS-CoV-2 infection, but not to the protection offered by vaccination.
Read More